Expert panel asks drug cos to submit subgroup data on Molnupiravir
Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of mild-to-moderate Covid-19 in adults.
via Economictimes
Post a Comment